COVID-19-associated dermatologic manifestations: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}} {{AE}}{{Nuha}} | {{CMG}} {{AE}}{{Nuha}} | ||
== | ==Overview== | ||
== | |||
== | ==Complications== | ||
===Complication1=== | |||
* | |||
===Complication2=== | |||
===Complication3=== | |||
===Complication4=== | |||
==References== |
Revision as of 16:37, 11 June 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Nuha Al-Howthi, MD[2]